U.S. court orders Guardant to pay $245 million in DNA sequencing patent dispute

A U.S. court has ordered Guardant Health to pay more than $245.2 million to TwinStrand Biosciences and the University ​of Washington after finding that the company infringed ‌patents covering DNA sequencing technology, TwinStrand said on Monday.